Mannkind (MNKD) Net Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.47% |
| Dec 31, 2025 | -361.83% |
| Sep 30, 2025 | 1,094.76% |
| Jun 30, 2025 | -94.92% |
| Mar 31, 2025 | 77.45% |
| Dec 31, 2024 | -35.80% |
| Sep 30, 2024 | 680.11% |
| Jun 30, 2024 | -118.73% |
| Mar 31, 2024 | 655.51% |
| Dec 31, 2023 | -18.25% |
| Sep 30, 2023 | 132.69% |
| Jun 30, 2023 | 46.25% |
| Mar 31, 2023 | 45.42% |
| Dec 31, 2022 | -24.36% |
| Sep 30, 2022 | 50.27% |
| Jun 30, 2022 | -11.64% |
| Mar 31, 2022 | 7.35% |
| Dec 31, 2021 | -534.00% |
| Sep 30, 2021 | 87.54% |
| Jun 30, 2021 | -175.03% |
| Mar 31, 2021 | 51.10% |
| Dec 31, 2020 | -134.66% |
| Sep 30, 2020 | -9.78% |
| Jun 30, 2020 | -9.98% |
| Mar 31, 2020 | 30.45% |
| Dec 31, 2019 | -29.26% |
| Sep 30, 2019 | 16.28% |
| Jun 30, 2019 | 16.77% |
| Mar 31, 2019 | -106.05% |
| Dec 31, 2018 | 70.11% |
| Sep 30, 2018 | -6.58% |
| Jun 30, 2018 | 25.37% |
| Mar 31, 2018 | -137.56% |
| Dec 31, 2017 | 345.99% |
| Sep 30, 2017 | 6.94% |
| Jun 30, 2017 | -116.48% |
| Mar 31, 2017 | -130.24% |
| Dec 31, 2016 | -57.34% |
| Sep 30, 2016 | 522.31% |
| Jun 30, 2016 | -20.45% |
| Mar 31, 2016 | -130.70% |
| Dec 31, 2015 | 354.35% |
| Sep 30, 2015 | -10.19% |
| Jun 30, 2015 | 5.70% |
| Mar 31, 2015 | 15.87% |
| Dec 31, 2014 | 0.22% |
| Sep 30, 2014 | 50.22% |
| Jun 30, 2014 | -40.93% |
| Mar 31, 2014 | 2.85% |
| Dec 31, 2013 | -5.44% |
| Sep 30, 2013 | -10.18% |
| Jun 30, 2013 | -12.59% |
| Mar 31, 2013 | 20.89% |
| Dec 31, 2012 | -20.89% |
| Sep 30, 2012 | -17.10% |
| Jun 30, 2012 | 4.18% |
| Mar 31, 2012 | -4.88% |
| Dec 31, 2011 | 5.22% |
| Sep 30, 2011 | 13.66% |
| Jun 30, 2011 | -7.12% |
| Mar 31, 2011 | -8.40% |
| Dec 31, 2010 | 15.44% |
| Sep 30, 2010 | -7.22% |